Cargando…
How Does the Mono-Triazole Derivative Modulate Aβ(42) Aggregation and Disrupt a Protofibril Structure: Insights from Molecular Dynamics Simulations
[Image: see text] Clinical studies have identified that abnormal self-assembly of amyloid-β (Aβ) peptide into toxic fibrillar aggregates is associated with the pathology of Alzheimer’s disease (AD). The most acceptable therapeutic approach to stop the progression of AD is to inhibit the formation of...
Autores principales: | Kaur, Amandeep, Kaur, Anupamjeet, Goyal, Deepti, Goyal, Bhupesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7331201/ https://www.ncbi.nlm.nih.gov/pubmed/32637837 http://dx.doi.org/10.1021/acsomega.0c01825 |
Ejemplares similares
-
Impact of Mutations
on the Conformational Transition
from α-Helix to β-Sheet Structures in Arctic-Type
Aβ(40): Insights from Molecular Dynamics Simulations
por: Saini, Rajneet Kaur, et al.
Publicado: (2020) -
Dynamics of protofibril elongation and association involved in Aβ42 peptide aggregation in Alzheimer’s disease
por: Ghosh, Preetam, et al.
Publicado: (2010) -
Increased Number of Plasma B Cells Producing Autoantibodies Against Aβ(42) Protofibrils in Alzheimer’s Disease
por: Söllvander, Sofia, et al.
Publicado: (2015) -
The Interplay between PolyQ and Protein Context Delays Aggregation by Forming a Reservoir of Protofibrils
por: Bulone, Donatella, et al.
Publicado: (2006) -
Insight Into Seeded Tau Fibril Growth From Molecular Dynamics Simulation of the Alzheimer’s Disease Protofibril Core
por: Leonard, Cass, et al.
Publicado: (2021)